The Paris office of Reed Smith has advised the Cap Horn fund in connection with the €10 million fundraising by Tilak Healthcare.

Profesionales relacionados:: Marco Hazan Guilain Hippolyte

Biotechnology human eye concept

Tilak Healthcare is a pioneering company and a major player in the field of ophthalmological digital health.

This round of funding will enable Tilak Healthcare to speed up the deployment in France and abroad of its OdySight application, a remote monitoring system for ophthalmological conditions combined with a game interface designed to encourage regular use by patients.

Cap Horn is a Paris-based private equity firm specialising in the healthtech and climatetech sectors. It supports high-potential companies and their founders at every stage of their development, through investments ranging from €1 million to €20 million. Cap Horn has an active portfolio of 15 healthtech companies whose mission is to optimise healthcare systems and personalise care pathways.

The Reed Smith team working alongside Cap Horn comprised partner Guilain Hippolyte and associate Marco Hazan.

Bird & Bird supported Tilak Healthcare in this transaction.

Jones Day accompanied Elaia Partners, also investors.